Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.87
-0.05-0.72%
At close: -
$6.95
0.081.16%
After Hours: 7:56 PM EDT
Comments
Loading...
Altimmune Analyst Ratings and Price Targets | NASDAQ:ALT | Benzinga
Altimmune Inc has a consensus price target of $22.3 based on the ratings of 12 analysts. The high is $35 issued by Jefferies on August 31, 2022. The low is $12 issued by HC Wainwright & Co. on April 3, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Citizens Capital Markets, and HC Wainwright & Co. on April 3, 2025, April 2, 2025, and March 18, 2025, respectively. With an average price target of $16.33 between HC Wainwright & Co., Citizens Capital Markets, and HC Wainwright & Co., there's an implied 135.01% upside for Altimmune Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citizens Capital Markets
Stifel
UBS
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for Altimmune
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/03/2025 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2025 | Buy Now | 259.71% | Citizens Capital Markets | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/18/2025 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2025 | Buy Now | 259.71% | Citizens Capital Markets | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/03/2025 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | — | William Blair | Andy Hsieh27% | — | Initiates | → Market Perform | Get Alert |
| 02/05/2025 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/23/2025 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 158.99% | Stifel | Annabel Samimy66% | → $18 | Initiates | → Buy | Get Alert |
| 11/14/2024 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 274.1% | UBS | Eliana Merle49% | → $26 | Initiates | → Buy | Get Alert |
| 08/22/2024 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 187.77% | B. Riley Securities | Mayank Mamtani72% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 06/25/2024 | Buy Now | 187.77% | B. Riley Securities | Mayank Mamtani72% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | 259.71% | Piper Sandler | Yasmeen Rahimi60% | $25 → $25 | Maintains | Overweight | Get Alert |
| 05/14/2024 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 245.32% | JMP Securities | Jonathan Wolleben72% | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 04/29/2024 | Buy Now | — | Guggenheim | Seamus Fernandez62% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/01/2024 | Buy Now | 72.66% | HC Wainwright & Co. | Patrick Trucchio51% | $15 → $12 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | 187.77% | B. Riley Securities | Mayank Mamtani72% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2024 | Buy Now | 187.77% | B. Riley Securities | Mayank Mamtani72% | → $20 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | 87.05% | Goldman Sachs | Corinne Jenkins47% | → $13 | Reinstates | → Neutral | Get Alert |
| 12/01/2023 | Buy Now | 115.83% | HC Wainwright & Co. | Patrick Trucchio51% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | 15.11% | B. Riley Securities | Mayank Mamtani72% | $15 → $8 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | 115.83% | HC Wainwright & Co. | Patrick Trucchio51% | $50 → $15 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 115.83% | B. Riley Securities | Mayank Mamtani72% | $20 → $15 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | 115.83% | JMP Securities | Jonathan Wolleben72% | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/15/2023 | Buy Now | 619.42% | HC Wainwright & Co. | Patrick Trucchio51% | → $50 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 115.83% | JMP Securities | Jonathan Wolleben72% | $15 → $15 | Reinstates | Market Outperform → Market Outperform | Get Alert |
| 03/31/2023 | Buy Now | 115.83% | JMP Securities | Jonathan Wolleben72% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 03/22/2023 | Buy Now | 274.1% | JMP Securities | Jonathan Wolleben72% | → $26 | Reiterates | → Market Outperform | Get Alert |
| 03/22/2023 | Buy Now | -13.67% | Goldman Sachs | Corinne Jenkins47% | $20 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 03/09/2023 | Buy Now | 619.42% | HC Wainwright & Co. | Patrick Trucchio51% | → $50 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | Buy Now | 274.1% | JMP Securities | Jonathan Wolleben72% | → $26 | Reiterates | → Market Outperform | Get Alert |
| 01/20/2023 | Buy Now | 619.42% | HC Wainwright & Co. | Patrick Trucchio51% | → $50 | Reiterates | → Buy | Get Alert |
| 01/18/2023 | Buy Now | 259.71% | Evercore ISI Group | Liisa Bayko70% | $14 → $25 | Maintains | Outperform | Get Alert |
| 12/01/2022 | Buy Now | 187.77% | Goldman Sachs | Corinne Jenkins47% | → $20 | Initiates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | 274.1% | JMP Securities | Jonathan Wolleben72% | $28 → $26 | Maintains | Market Outperform | Get Alert |
| 09/16/2022 | Buy Now | 274.1% | Guggenheim | Seamus Fernandez62% | $31 → $26 | Maintains | Buy | Get Alert |
| 08/31/2022 | Buy Now | 403.6% | Jefferies | Roger Song36% | $30 → $35 | Maintains | Buy | Get Alert |
| 08/17/2022 | Buy Now | 619.42% | HC Wainwright & Co. | Patrick Trucchio51% | $25 → $50 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 274.1% | B. Riley Securities | Mayank Mamtani72% | $21 → $26 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Altimmune (ALT) stock?
The latest price target for Altimmune (NASDAQ:ALT) was reported by HC Wainwright & Co. on April 3, 2025. The analyst firm set a price target for $12.00 expecting ALT to rise to within 12 months (a possible 72.66% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Altimmune (ALT)?
The latest analyst rating for Altimmune (NASDAQ:ALT) was provided by HC Wainwright & Co., and Altimmune reiterated their buy rating.
When was the last upgrade for Altimmune (ALT)?
There is no last upgrade for Altimmune
When was the last downgrade for Altimmune (ALT)?
The last downgrade for Altimmune Inc happened on April 29, 2024 when Guggenheim changed their price target from N/A to N/A for Altimmune Inc.
When is the next analyst rating going to be posted or updated for Altimmune (ALT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Altimmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Altimmune was filed on April 3, 2025 so you should expect the next rating to be made available sometime around April 3, 2026.
Is the Analyst Rating Altimmune (ALT) correct?
While ratings are subjective and will change, the latest Altimmune (ALT) rating was a reiterated with a price target of $12.00 to $12.00. The current price Altimmune (ALT) is trading at is $6.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
